Our formulations incorporate liposomal delivery, meaning they are better for you on a cellular level by offering superior absorption for maximum benefits
Annu Rev Immunol (2014) 32:60934
Aminian A, Kashyap SR, Wolski KE et al (2021) Patient-reported outcomes after metabolic surgery versus medical therapy for diabetes: insights from the STAMPEDE randomized trial
Retatrutide is an investigational triple incretin receptor agonist not yet approved by the MHRA or EMA for use in the UK, meaning its use outside regulated clinical trials is unlawful
The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial
Emerging evidence suggests L-carnitine may support signaling pathways involved in mitochondrial enzyme activity, fat oxidation gene expression, and long-term metabolic adaptations to training Sounds pretty good, doesnt it